Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Clinical trial NCT00866697 · COMPLETED
Trial details
- NCT number
- NCT00866697
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-26
- Primary completion
- 2012-07-08
- Enrollment
- 940
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.